Analysis of the Effect of Chronic Morphine Treatment on miRNA Profile and Introduction of the MAPK Pathway as the Target of Differentially Expressed miRNAs

Authors
R. Nakhaei Sistani 1
B. Mohammad Soltani 2
M. Sadeghizadeh 3
M. Sadeghizadeh 3
1 Ph.D. Candidate, Department of Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Assistant Professor, Department of Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 Professor, Department of Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Abstract
Objective: Different signaling pathways have been identified that are involved in the cellular response to opiates. The mitogen-activated protein kinase pathway is one of the most important signaling pathways underlying the neuronal response to opiates. MicroRNAs (miRNAs) are considered to be post-transcriptional regulators of gene expression with paramount significance, which plays key roles in modulating cellular processes such as neuronal plasticity and synaptic consolidation. The purpose of this study is to identify miRNAs that are differentially expressed in response to chronic morphine treatment, and predict those genes that have a possible role in this process. Because the MAPK pathway in involved in morphine dependence and participates in hypersensitivity to pain, determining miRNAs that modulate this pathway could be insightful in morphine dependence treatment and pain control.
Methods: In this study, the BE(2)-C neuroblastoma cell line was chronically treated with morphine sulphate and the changes in expression of 750 miRNAs were analyzed by real time PCR.
Results: Two up- and down- regulated groups of miRNAs were determined to be differentially expressed in response to morphine: i) has-mir-193a-3p, -212, -181c, -362-3p, -639, -646 and ii) has-mir-412, -937, -558, -552, -943, -628-5p, -593, -555, -636, -643, 566, -571, -642, -653, -611, -31, let7-g.
Conclusion: The analysis of differentially expressed miRNAs showed that the MAPK signaling pathway could be regarded as a signaling pathway with utmost significance in chronic morphine response. Due to the role played by MAPK pathway in cellular response to morphine exposure, we can propose that protein phosphorylation has a presumable part in this response.

Keywords

[1]     Spanagel R, Heilig M. Addiction and its brain science. Addiction 2005; 100(12): 1813-22.
[2]     Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103(7): 1069-81.
[3]     Chen Y, Sommer C. The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol 2009; 40(2): 101-7.
[4]     Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009; 60(1): 135-48.
[5]     Mayer DJ, Mao J, Holt J, Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999; 96(14): 7731-6.
[6]     Thomas MJ, Kalivas PW, Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 2008; 154(2): 327-42.
[7]     Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev 2004; 18(5): 504-11.
[8]     Babashah S, Sadeghizadeh M, Tavirani MR, Farivar S, Soleimani M. Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell Oncol (Dordr) 2012; 35(5): 317-34.
[9]     Hausser J, Landthaler M, Jaskiewicz L, Gaidatzis D, Zavolan M. Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets. Genome Res 2009; 19(11): 2009-20.
[10]  Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27(1): 91-105.
[11]  Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
[12]  Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15(5): 563-8.
[13]  Dreyer JL. New insights into the roles of microRNAs in drug addiction and neuroplasticity. Genome Med 2010; 2(12): 92.
[14]  Rodríguez RE. Morphine and microRNA Activity: Is There a Relation with Addiction? Front Genet 2012; 3: 223.
[15]  Dave RS, Khalili K. Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem 2010; 110(4): 834-45.
[16]  Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2): 55-63.
[17]  Talebi M, Mashayekhi M, Rajabi S, Rahmani MR, Roohbakhsh A, Shamsizadeh A. Effect of chronic morphine treatment on tactile learning in rat. Afr J Pharm Pharmacol 2011; 5(19): 2128-31.
[18]  Zheng H, Chu J, Zeng Y, Loh HH, Law PY. Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem 2010; 285(29): 21994-2002.
[19]  Bilecki W, Zapart G, Ligeza A, Wawrzczak-Bargiela A, Urbański MJ, Przewłocki R. Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment. Cell Mol Life Sci 2005; 62(19-20): 2369-75.
[20]  Sanchez-Simon FM, Zhang XX, Loh HH, Law PY, Rodriguez RE. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol 2010; 78(5): 935-42.
[21]  Valjent E, Pagès C, Hervé D, Girault JA, Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004; 19(7): 1826-36.
[22]  Rohde DS, McKay WR, Abbadie C, Basbaum AI. Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat. Brain Res 1997; 745(1-2): 83-95.
[23]  Cui Y, Chen Y, Zhi JL, Guo RX, Feng JQ, Chen PX. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 2006; 1069(1): 235-43.
[24]  Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 2001; 14(7): 1091-104.
[25]  Obata K, Katsura H, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Noguchi K. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J Neurochem 2007; 102(5): 1569-84.
[26]  Li CY, Mao X, Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008; 4(1): e2.
Pathobiology Reserach
Volume 15, Issue 4
February 2013
Pages 89-98